NCT07123935View on ClinicalTrials.gov

Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

June 30, 2027

Conditions
Cardiac Surgery Associated - Acute Kidney InjuryAKI - Acute Kidney Injury
Interventions
DEVICE

RenalGuard® Therapy

RenalGuard Therapy®

OTHER

Standard of Care (SOC)

Standard of care

Trial Locations (2)

Unknown

Institut Jantung Negara, Kuala Lumpur

Universiti Malaya Medical Centre, Kuala Lumpur

Sponsors
All Listed Sponsors
collaborator

University Malaysia Medical Centre

UNKNOWN

collaborator

Institut Jantung Negara

OTHER

lead

CardioRenal Systems, Inc.

INDUSTRY

NCT07123935 - Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury | Biotech Hunter | Biotech Hunter